Similar findings were also shown in work by Yu et al,25 in which in 47 HER2+ breast cancer patients receiving anthracyclines and trastuzumab there was no association between MHD and changes in LVEF, strain, and diastolic indices 6 months after RT. Here, ERBB2 is linked to breast carcinoma.